RDIA
FLGT icon

RE Dickinson Investment Advisors’s Fulgent Genetics FLGT Stock Holding History

RE Dickinson Investment Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31
Closed -$1K – 241
2023
Q3 		$1K Hold
31
– – ﹤0.01% 250
2023
Q2 		$1K Hold
31
– – ﹤0.01% 359
2023
Q1 		$1K Hold
31
– – ﹤0.01% 381
2022
Q4 		$1K Hold
31
– – ﹤0.01% 364
2022
Q3 		$1K Hold
31
– – ﹤0.01% 236
2022
Q2 		$2 Hold
31
– – ﹤0.01% 242
2022
Q1 		$2K Buy
31
+1
+3% +$66 ﹤0.01% 257
2021
Q4 		$3K Buy
+30
New +$2.64K ﹤0.01% 236

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RE Dickinson Investment Advisors's FLGT Position: Q4 2023 in Review

RE Dickinson Investment Advisors sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 31 shares — an estimated $1K sold.

RE Dickinson Investment Advisors first reported a position in FLGT in Q4 2021 and held it in 8 quarters. The position peaked at $3K in Q4 2021. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • RE Dickinson Investment Advisors reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • RE Dickinson Investment Advisors sold 31 Fulgent Genetics shares in Q4 2023, an estimated $1K.
  • RE Dickinson Investment Advisors first reported a position in Fulgent Genetics in Q4 2021 and held it in 8 quarters.
  • RE Dickinson Investment Advisors's Fulgent Genetics position peaked at $3K in Q4 2021.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on RE Dickinson Investment Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.